SHARE
COPY LINK

HEALTH

Switzerland sees Europe’s biggest surge in Covid-19 cases

Europe has seen a huge surge in Covid-19 infections in recent days with Switzerland topping the table for the biggest growth rate.

Switzerland sees Europe's biggest surge in Covid-19 cases
AFP

Around the world the pandemic has continued to pick up speed over the past  week, with 342,550 new daily cases, an increase of nine percent over the previous week, according to an AFP tally on Friday at 11am GMT.

But it is in Europe that the rate of infections has increased most, spiralling by a huge 44 percent. The number of new average daily cases there is around 121,227, against 84,400 the previous week.

The number of cases also rose in Oceania by 66 percent, in North America by 17 percent and Africa by 16 percent.

However the number of infections has decreased in Latin America and the Caribbean and in the Middle East by 15 percent, as well as in Asia (down by seven percent).

The number of confirmed cases only reflects a fraction of the actual number of infections, as different countries have different counting practices and levels of testing.

Biggest increases

It is in Switzerland where the pandemic is growing most with a 146 percent rise, or 1,771 new daily cases on average, among the countries which have recorded more than 1,000 daily cases over the past week.

Chart from Our World in Data

Belgium follows with 125 percent, or 6,235 cases, Poland (111 percent, 5,472 cases) Italy (106 percent, 6,172 cases) and Slovakia (78 percent, 1,214 cases).

On Friday Switzerland reported another 3,105 new infections, setting a new record for a second consecutive day, albeit the country is carrying out more tests than it did back in the spring when the pandemic first hit.

There have been a total of 74,422 confirmed cases in Switzerland and the neighbouring principality of Liechtenstein. The death toll in the country rose by 5 to 1,823 on Friday. 

 

 

 

Chart from Our World in Data

 

On Thursday the country's health minister warned that the situation was “deteriorating” at an alarming rate.

“We have in recent days faced a new dynamic, which is very negative and very strong,” Alain Berset told reporters. “For the past week, he said “the situation in Switzerland is deteriorating faster than elsewhere.”

The proportion of positive tests in the country has meanwhile jumped from 5.4 to 10.2 percent in the past week.

Swiss President Simonetta Sommaruga warned Thursday that a full-blown second wave was looming. “It is five minutes to midnight,” she told reporters, urging everyone in the country to take precautions.

“The swifter we act, the less restrictions there will be for the population, the economy, families and risk groups,” she said, urging everyone to “work together”.

 

 

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.
For members

HEALTH

Which medications in Switzerland are set to become more expensive?

The cost of medications in Switzerland is already quite a bit higher than elsewhere in Europe. And now certain drugs will become even pricier.

Which medications in Switzerland are set to become more expensive?

Swiss consumers pay significantly more for their medicines than those in neighbouring European countries. 

This is what emerges from various data published over the years.

“In Switzerland, we pay far too much for medicines compared to abroad,” Matthias Müller, a spokesperson for SantéSuisse, an umbrella group for Swiss health insurance providers, told Swiss media in 2023. 

Even the price of many generic medicines is twice as high in Switzerland as in nine EU countries.

For instance, generics are on average 48 percent cheaper in Belgium, Denmark, Germany, Finland, France, Great Britain, the Netherlands, Austria and Sweden than in Switzerland, according to a price comparison.

And prices for a number of commonly-used drugs will rise even further in the near future.

Why is that?

The Federal Office of Public Health (FOPH) is adapting a new model for calculating the distribution margin. 

A distribution margin is the difference between the distributor’s cost of acquiring goods and the price at which those goods are sold.

From July 1st, 2024, inexpensive medicines whose factory price is less than, or equal to, 15 francs will become more expensive.

This change will affect more than half of medications currently being sold in Switzerland.

As a result of this move, “additional costs of several hundred million will be passed on to patients,” according to Intergenrika, which represents generic drug manufacturers in Switzerland. 

In a nutshell, consumers will pay slightly lower prices for medicines that were previously more expensive, but will also end up paying more  for those that are currently cheaper – like generics.

Which meds will become more expensive?

Pain medications are among those set to become pricier.

One of them is ibuprofen, a popular anti-inflammatory.

While a box of 20 400-mg tablets today costs 5.92 francs, its price will practically double to 11 francs from July 1st.

Though its manufacturing cost will remain the same as today – 1.58 francs – the distribution margin will increase from 4.19 to 9.09 francs.

The same goes for another often-used pain medication, Ponstan.

Ten 500-mg tablets will cost 11.21 francs instead of 6.19 currently.

The manufacturer will continue to charge 1.82 francs for the drug, but the distribution margin will increase from 4.22 to 9.11 francs.

And even generic drugs, which are cheaper – and often by much – will get pricier, at consumers’ expense.

Will some drugs be cheaper?

Yes, some will become slightly less expensive.

One example is the anticoagulant Rivaroxaban whose price will drop from 281 to 267 francs.

READ ALSO: Why you will pay more for certain drugs in Switzerland 2024?

SHOW COMMENTS